Nedelman JR - Search Results

1

Perspectives in pharmacokinetics. Physiologically based pharmacokinetic modeling as a tool for drug development.

Charnick SB, Kawai R, Nedelman JR, Lemaire M, Niederberger W, Sato H. Charnick SB, et al. Among authors: nedelman jr. J Pharmacokinet Biopharm. 1995 Apr;23(2):217-29. doi: 10.1007/BF02354273. J Pharmacokinet Biopharm. 1995. PMID: 8719238 Review.

2

Efficacy and pharmacokinetics of two formulations of cyclosporine A in patients with psoriasis.

Elder CA, Moore M, Chang CT, Jin J, Charnick S, Nedelman J, Cohen A, Guzzo C, Lowe N, Simpson K, et al. Elder CA, et al. J Clin Pharmacol. 1995 Sep;35(9):865-75. doi: 10.1002/j.1552-4604.1995.tb04131.x. J Clin Pharmacol. 1995. PMID: 8786246 Clinical Trial.

3

Description of blood pressure changes in patients beginning cyclosporin A therapy.

Charnick SB, Nedelman JR, Chang CT, Hwang DS, Jin J, Moore MA, Wong R, Meligeni J. Charnick SB, et al. Among authors: nedelman jr. Ther Drug Monit. 1997 Feb;19(1):17-24. doi: 10.1097/00007691-199702000-00003. Ther Drug Monit. 1997. PMID: 9029741 Clinical Trial.

4

Assessing drug exposure in rodent toxicity studies without satellite animals.

Nedelman JR, Gibiansky E, Tse FL, Babiuk C. Nedelman JR, et al. J Pharmacokinet Biopharm. 1993 Jun;21(3):323-34. doi: 10.1007/BF01059783. J Pharmacokinet Biopharm. 1993. PMID: 8258771

5

Multiple-dose pharmacokinetics of a long half-life drug: contributions of mathematical modeling.

Nedelman JR, Gibiansky E, Cramer J, Kovarik J, Meligeni J, Robbins B. Nedelman JR, et al. Eur J Drug Metab Pharmacokinet. 1997 Apr-Jun;22(2):179-84. doi: 10.1007/BF03189803. Eur J Drug Metab Pharmacokinet. 1997. PMID: 9248788

6

A nonlinear mixed-effects pharmacokinetic model comparing two formulations of cyclosporine in stable renal transplant patients.

Sallas WM, Nedelman JR, Sheiner LB, Meligeni JA, Robinson WT. Sallas WM, et al. Among authors: nedelman jr. J Pharmacokinet Biopharm. 1995 Oct;23(5):495-514. doi: 10.1007/BF02353471. J Pharmacokinet Biopharm. 1995. PMID: 8656344

7

The effect of food on the pharmacokinetics of multiple-dose terbinafine in young and elderly healthy subjects.

Nedelman J, Cramer JA, Robbins B, Gibiansky E, Chang CT, Gareffa S, Cohen A, Meligeni J. Nedelman J, et al. Biopharm Drug Dispos. 1997 Mar;18(2):127-38. doi: 10.1002/(sici)1099-081x(199703)18:2<127::aid-bdd6>3.0.co;2-8. Biopharm Drug Dispos. 1997. PMID: 9099449 Clinical Trial.

8

Population Pharmacokinetics of Subcutaneous Pasireotide in Healthy Volunteers and Cushing's Disease Patients.

Nedelman J, Fisch R, Hu K, Paule I, Zhou J. Nedelman J, et al. Clin Pharmacokinet. 2018 Jul;57(7):855-866. doi: 10.1007/s40262-017-0600-y. Clin Pharmacokinet. 2018. PMID: 29032486 Clinical Trial.

9

Inferring systemic exposure from a pharmacokinetic screen: model-free and model-based approaches.

Nedelman JR, Karara AH, Chang CT, Gibiansky E, McDonald S, Robinson WT. Nedelman JR, et al. Stat Med. 1995 May 15-30;14(9-10):955-68; discussion 969-70. doi: 10.1002/sim.4780140915. Stat Med. 1995. PMID: 7569513

10

Errors in time in pharmacokinetic studies.

Jia X, Nedelman JR. Jia X, et al. Among authors: nedelman jr. J Biopharm Stat. 1996 Jul;6(3):303-18. doi: 10.1080/10543409608835145. J Biopharm Stat. 1996. PMID: 8854234

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40 results

Search Page

Filters